Inhibition of hepatocyte apoB secretion by naringenin

Nica M. Borradaile(Western University), Murray W. Huff(Western University)

Journal of Lipid Research

September 1, 2002

10.1194/jlr.m200115-jlr200

Cited by 79

Related Papers

Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death

|Journal of Lipid Research|2006|566

Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance

|Diabetes|2011|201

Inhibition of Microsomal Triglyceride Transfer Protein Expression and Apolipoprotein B100 Secretion by the Citrus Flavonoid Naringenin and by Insulin Involves Activation of the Mitogen-Activated Protein Kinase Pathway in Hepatocytes

|Diabetes|2005|114

Elongation Factor 1A-1 Is a Mediator of Hepatocyte Lipotoxicity Partly through Its Canonical Function in Protein Synthesis

|PLoS ONE|2015|21

Treatment with didemnin B, an elongation factor 1A inhibitor, improves hepatic lipotoxicity in obese mice

|Physiological Reports|2016|19